Stockscreener 앱 받기
76.06
1.77%
1.32
시장 영업 전:
75.95
-0.11
-0.14%
전일 마감가:
$74.74
열려 있는:
$76.58
하루 거래량:
902.31K
Relative Volume:
1.17
시가총액:
$5.20B
수익:
-
순이익/손실:
$-146.66M
주가수익비율:
-27.62
EPS:
-2.7541
순현금흐름:
$-133.21M
1주 성능:
+2.03%
1개월 성능:
+33.98%
6개월 성능:
+81.01%
1년 성능:
+57.21%
1일 변동 폭
$74.00
$76.75
1주일 범위
$70.54
$77.08
52주 변동 폭
$26.20
$77.08
Apogee Therapeutics Inc Stock (APGE) Company Profile
명칭
Apogee Therapeutics Inc
전화
650-394-5230
주소
221 CRESCENT ST., WALTHAM
APGE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
76.06 | 5.11B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 개시 | Deutsche Bank | Buy |
| 2025-11-03 | 개시 | Craig Hallum | Buy |
| 2025-10-21 | 개시 | Mizuho | Outperform |
| 2025-09-25 | 개시 | RBC Capital Mkts | Outperform |
| 2025-07-07 | 재확인 | BTIG Research | Buy |
| 2025-03-13 | 개시 | Citigroup | Buy |
| 2024-11-25 | 개시 | Canaccord Genuity | Buy |
| 2024-05-10 | 개시 | BofA Securities | Buy |
| 2023-12-20 | 개시 | BTIG Research | Buy |
| 2023-08-08 | 개시 | Guggenheim | Buy |
| 2023-08-08 | 개시 | Jefferies | Buy |
| 2023-08-08 | 개시 | Stifel | Buy |
| 2023-08-08 | 개시 | TD Cowen | Outperform |
| 2023-08-08 | 개시 | Wedbush | Outperform |
모두보기
Apogee Therapeutics Inc 주식(APGE)의 최신 뉴스
Deutsche Bank Initiates Apogee Therapeutics at Buy With $103 Price Target - marketscreener.com
Deutsche Bank Initiates Coverage of Apogee Therapeutics (APGE) with Buy Recommendation - Nasdaq
Apogee Therapeutics stock initiated with Buy rating at Deutsche Bank - Investing.com
Apogee Therapeutics stock initiated with Buy rating at Deutsche Bank By Investing.com - Investing.com India
Strong Pipeline and Analyst Confidence Push Apogee Therapeutics Inc. (APGE) Toward Growth - Yahoo Finance
Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - The Manila Times
Certain Restricted Stock Units of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 8-DEC-2025. - marketscreener.com
Certain Stock Options of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 8-DEC-2025. - marketscreener.com
Apogee Therapeutics (NASDAQ:APGE) CEO Sells $3,000,400.00 in Stock - MarketBeat
Carl Dambkowski Sells 10,900 Shares of Apogee Therapeutics (NASDAQ:APGE) Stock - MarketBeat
Schroder Investment Management Group Boosts Stock Position in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics CMO sells $817k in stock By Investing.com - Investing.com South Africa
Insider Sell: Jane Henderson Sells 1,500 Shares of Apogee Therap - GuruFocus
Apogee Therapeutics CEO Henderson sells $3.0 million in stock By Investing.com - Investing.com Canada
Apogee Therapeutics CFO Henderson sells $112,500 in shares - Investing.com India
Apogee Therapeutics CMO sells $817k in stock - Investing.com
Apogee Therapeutics CFO Henderson sells $112,500 in shares By Investing.com - Investing.com UK
CFO Henderson Sells 1,500 ($112.5K) Of Apogee Therapeutics Inc [APGE] - TradingView
CEO Henderson Sells 40,000 ($3M) Of Apogee Therapeutics Inc [APGE] - TradingView
Apogee Therapeutics (NASDAQ:APGE) Hits New 12-Month HighHere's What Happened - MarketBeat
Prudential Financial Inc. Has $2.99 Million Stake in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics stock hits all-time high at 73.99 USD By Investing.com - Investing.com Australia
Apogee Therapeutics stock hits all-time high at 73.99 USD - Investing.com
Transcript : Apogee Therapeutics, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-03-2025 09 - marketscreener.com
(APGE) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
How Apogee Therapeutics Inc. stock benefits from global expansionWeekly Profit Recap & Long-Term Growth Portfolio Plans - BỘ NỘI VỤ
Henderson, Apogee Therapeutics CFO, sells $105k in stock By Investing.com - Investing.com Canada
Apogee Therapeutics CFO Sells 1,500 Shares - TradingView
CFO Henderson Sells 1,500 ($105K) Of Apogee Therapeutics Inc [APGE] - TradingView
BofA Raises Apogee Therapeutics (APGE) PT to $87 Following Positive Phase 2 APEX Trial Results for Atopic Dermatitis - MSN
Franklin Resources Inc. Lowers Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat
Geode Capital Management LLC Has $33.99 Million Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics (NASDAQ:APGE) Hits New 1-Year HighHere's Why - MarketBeat
Apogee Therapeutics Inc. $APGE Position Boosted by Jefferies Financial Group Inc. - MarketBeat
Is Apogee Therapeutics Inc a good long term investmentInsider Trading Compliance & High Yield Trading Alerts - earlytimes.in
Responsive Playbooks and the APGE Inflection - news.stocktradersdaily.com
Apogee Therapeutics (NASDAQ:APGE) Hits New 52-Week HighHere's What Happened - MarketBeat
Apogee Therapeutics stock hits 52-week high at $67.66 By Investing.com - Investing.com Nigeria
Apogee Therapeutics stock hits 52-week high at $67.66 - Investing.com
Is Apogee Therapeutics Inc. stock recession proofWeekly Stock Summary & High Conviction Buy Zone Picks - newser.com
How to track smart money flows in Apogee Therapeutics Inc.2025 Price Momentum & Daily Market Momentum Tracking - newser.com
How to use Fibonacci retracement on Apogee Therapeutics Inc.Market Activity Recap & Risk Controlled Stock Pick Alerts - newser.com
Apogee Therapeutics (NASDAQ:APGE) Rating Increased to Hold at Wall Street Zen - MarketBeat
How to integrate Apogee Therapeutics Inc. into portfolio analysis toolsPortfolio Value Report & Expert Approved Momentum Ideas - newser.com
Published on: 2025-11-15 19:11:00 - newser.com
Assessing Apogee Therapeutics (APGE) Valuation After Recent Surge in Investor Interest - Yahoo Finance
Why Apogee Therapeutics (APGE) Is Up 19.7% After Strong APG333 Trial Data and Cash Infusion - Yahoo Finance
Can volume confirm reversal in Apogee Therapeutics Inc.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Insider Sell Alert: Jane Henderson Sells 2,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus
Henderson Jane, CFO of Apogee Therapeutics, sells $130k in stock - Investing.com Canada
Apogee Therapeutics Inc (APGE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
0.12%
자본화:
|
볼륨(24시간):